A Case Report on Ceftriaxone Induced Immediate Allergic Reaction

Authors

  • Ambika Nand Jha Indubhai Patel College of Pharmacy & Research Centre, Dharmaj, Anand Gujarat 388430
  • Akshay H. Shah Indubhai Patel College Of Pharmacy & Research Centre, Dharmaj,Anand, Gujarat, India 388430.
  • Upama N Trivedi Indubhai Patel College Of Pharmacy & Research Centre, Dharmaj,Anand, Gujarat, India 388430.

Keywords:

Ceftriaxone, Hypersensitivity, Cephalosporin, Itching

Abstract

The most common classes of drugs causing hypersensitivity reaction are antibiotics especially β-lactam antibiotic: cephalosporin’s and penicillin’s. Ceftriaxone, a third generation cephalosporin is used for variety of infections. This drug is associated with rare as well as mild side-effects such as urticaria, skin rash, diarrhea, vomiting, transient neutropenia, and hemolytic anaemia etc. We hereby try to present an adversary case report of a 19 years old male patient in which  ceftriaxone-induced  Immediate Allergic Reaction develop within 12 hour. Ceftriaxone induced Immediate Allergic Reaction is rare but could be severe if not treated. Management of Hypersensitivity reactions: Mild-moderate hypersensitivity reactions are managed by antihistamines and corticosteroids. This case is the evidence against Ceftriaxone Immediate Allergic Reaction

 

Keywords: Ceftriaxone, Hypersensitivity, Cephalosporin, Itching, Registered Medical Practitioner.

 

Cite this Article

Ambika Nand Jha, Akshay H. Shah, Upama N. Trivedi. A Case Report on Ceftriaxone Induced Immediate Allergic Reaction. Research & Reviews: A Journal of Pharmacology. 2020; 10(2): 33–35p.

Author Biographies

  • Ambika Nand Jha, Indubhai Patel College of Pharmacy & Research Centre, Dharmaj, Anand Gujarat 388430

    Department of Pharmacy Practice

  • Akshay H. Shah, Indubhai Patel College Of Pharmacy & Research Centre, Dharmaj,Anand, Gujarat, India 388430.
    Department of Pharmacology
  • Upama N Trivedi, Indubhai Patel College Of Pharmacy & Research Centre, Dharmaj,Anand, Gujarat, India 388430.
    Department of Pharmacology

Downloads

Additional Files

Published

2020-09-10

Issue

Vol. 10 No. 2 (2020)

Section

Case Study

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.